{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:13:01Z","timestamp":1754107981737},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.bbrc.2013.08.052","type":"journal-article","created":{"date-parts":[[2013,8,26]],"date-time":"2013-08-26T01:15:23Z","timestamp":1377479723000},"page":"359-363","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["A compound CP-31398 suppresses excitotoxicity-induced neurodegeneration"],"prefix":"10.1016","volume":"440","author":[{"given":"Takeshi","family":"Fujiwara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2013.08.052_b0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1471-4159.2008.05754.x","article-title":"Axonal degeneration and regeneration: a mechanistic tug-of-war","volume":"108","author":"Hilliard","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2013.08.052_b0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tins.2007.02.004","article-title":"Neuronal death: where does the end begin?","volume":"30","author":"Conforti","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbrc.2013.08.052_b0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1371\/journal.pgen.0010004","article-title":"Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage","volume":"1","author":"Libby","year":"2005","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbrc.2013.08.052_b0020","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.15-11-07727.1995","article-title":"Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease","volume":"15","author":"Sagot","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2013.08.052_b0025","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.cub.2004.01.053","article-title":"Wld(s)-mediated protection of dopaminergic fibers in an animal model of Parkinson disease","volume":"14","author":"Sajadi","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbrc.2013.08.052_b0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.expneurol.2006.05.017","article-title":"Wld(S) mice are protected against the Parkinsonian mimetic MPTP","volume":"202","author":"Hasbani","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbrc.2013.08.052_b0035","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nn1653","article-title":"Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF","volume":"9","author":"Pun","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbrc.2013.08.052_b0040","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1073\/pnas.0508774103","article-title":"Chronic activation in presymptornatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL","volume":"103","author":"Raoul","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2013.08.052_b0045","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00424-010-0809-1","article-title":"Glutamate receptors, neurotoxicity and neurodegeneration","volume":"460","author":"Lau","year":"2010","journal-title":"Pflugers. Arch-Eur. J. Physiol."},{"key":"10.1016\/j.bbrc.2013.08.052_b0050","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1523\/JNEUROSCI.13-05-02085.1993","article-title":"Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons","volume":"13","author":"Tymianski","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2013.08.052_b0055","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrd1958","article-title":"Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond","volume":"5","author":"Lipton","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2013.08.052_b0060","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/nn936","article-title":"NMDA receptor pathways as drug targets","volume":"5","author":"Kemp","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbrc.2013.08.052_b0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.coph.2005.09.007","article-title":"Mechanism of action of memantine","volume":"6","author":"Johnson","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bbrc.2013.08.052_b0070","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1106668","article-title":"Donepezil and memantine for moderate-to-severe Alzheimer\u2019s disease","volume":"366","author":"Howard","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2013.08.052_b0075","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1126\/science.286.5449.2507","article-title":"Pharmacological rescue of mutant p53 conformation and function","volume":"286","author":"Foster","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2013.08.052_b0080","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4161\/cbt.1.1.41","article-title":"The mutant p53-conformation modifying drug, CP-31398, can induce apoptosis of human cancer cells and can stabilize wild-type p53 protein","volume":"1","author":"Takimoto","year":"2002","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.bbrc.2013.08.052_b0085","doi-asserted-by":"crossref","DOI":"10.1111\/j.1471-4159.2012.07746.x","article-title":"Dynein and dynactin components modulate neurodegeneration induced by excitotoxicity","volume":"122","author":"Fujiwara","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbrc.2013.08.052_b0090","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbrc.2012.06.071","article-title":"Cooperative effect of p150Glued and microtubule stabilization to suppress excitotoxicity-induced axon degeneration","volume":"424","author":"Fujiwara","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2013.08.052_b0095","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbrc.2012.09.017","article-title":"Inhibition of p53 transactivation functionally interacts with microtubule stabilization to suppress excitotoxicity-induced axon degeneration","volume":"427","author":"Fujiwara","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2013.08.052_b0100","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1126\/science.285.5434.1733","article-title":"A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy","volume":"285","author":"Komarov","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2013.08.052_b0105","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nchembio809","article-title":"Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation","volume":"2","author":"Strom","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbrc.2013.08.052_b0110","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1006\/excr.2002.5526","article-title":"The p53 stabilizing compound CP-31398 induces apoptosis by activating the intrinsic bax\/mitochondrial\/caspase-9 pathway","volume":"276","author":"Luu","year":"2002","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrc.2013.08.052_b0115","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.1074\/jbc.M413863200","article-title":"Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport","volume":"280","author":"Takeuchi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2013.08.052_b0120","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1128\/MCB.23.6.2171-2181.2003","article-title":"Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding","volume":"23","author":"Wang","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbrc.2013.08.052_b0125","doi-asserted-by":"crossref","first-page":"45887","DOI":"10.1074\/jbc.M401854200","article-title":"CP-31398 restores DNA-binding activity to mutant p53 in vitro but does not affect p53 homologs p63 and p73","volume":"279","author":"Demma","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2013.08.052_b0130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1440-1681.1995.tb02004.x","article-title":"Glutamate-induced calcium loads: effects on energy metabolism and neuronal viability","volume":"22","author":"Thayer","year":"1995","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.bbrc.2013.08.052_b0135","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1152\/jn.1996.76.3.1611","article-title":"Sequestration of glutamate-induced Ca2+ loads by mitochondria in cultured rat hippocampal neurons","volume":"76","author":"Wang","year":"1996","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.bbrc.2013.08.052_b0140","doi-asserted-by":"crossref","first-page":"11003","DOI":"10.1073\/pnas.0604507103","article-title":"Small-molecule modulators of p53 family signaling and antitumor effects in p53-deficient human colon tumor xenografts","volume":"103","author":"Wang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbrc.2013.08.052_b0145","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1172\/JCI32481","article-title":"CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice","volume":"117","author":"Tang","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbrc.2013.08.052_b0150","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1523\/JNEUROSCI.16-04-01337.1996","article-title":"Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death","volume":"16","author":"Morrison","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbrc.2013.08.052_b0155","doi-asserted-by":"crossref","first-page":"6753","DOI":"10.1523\/JNEUROSCI.16-21-06753.1996","article-title":"Evidence for p53-mediated modulation of neuronal viability","volume":"16","author":"Xiang","year":"1996","journal-title":"J. Neurosci."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13013892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X13013892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,21]],"date-time":"2019-07-21T20:38:25Z","timestamp":1563741505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X13013892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0006291X13013892"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.08.052","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A compound CP-31398 suppresses excitotoxicity-induced neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2013.08.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}